Karaciğer Nakli Yapılmış Bir Hastada Açık Kalp Cerrahisi: Olgu Sunumu
Karaciğer nakli olan hasta sayısı arttıkça, geç dönemde gelişen kalp ve diğer sistem patolojileri Damar Cerrahisi Kliniği, Florya, İstanbul, nedeniyle cerrahi uygulamaları da sıklaşmıştır. Karaciğer nakli olan hastalarda koroner arter hastalığının görülme oranı artmaktadır. Karaciğer transplantı hastaları, asemptomatik olsa bile, koroner arter hastalığı için yüksek risk alt grubudur. Karaciğer transplantı gerçekleştirilen bir Turkey. hastada koroner arter hastalığı gelişmesi, kötü bir prognostik faktördür; Bu nedenle, risk altındaki kişilerin belirlenmesi klinik önceliğe sahip olmalıdır. Bu çalışmamızda, on iki yıl önce karaciğer nakli uygulanan 68 yaşındaki bir erkek hastaya iskemik kalp hastalığı tanısı ile kardiopulmoner Çıkar Çatışması: Yazarlar çıkar çatışması.
Open Heart Surgery In A Patient With Liver Transplantation: A Case Report
As the number of patients with liver transplantation increased, surgical applications were also frequent due to late-onset heart and other systemic pathologies. The incidence of coronary artery disease is increasing in patients with liver transplantation. Liver transplanted patients are a high risk subgroup for coronary artery disease, even if they are asymptomatic. Coronary artery disease is a predictor of poor outcomes in patients with liver transplantation; therefore, identiŞcation of those Sorumlu yazar / Corresponding author patients at risk for coronary artery disease should be a key clinical priority. In this study, it was Melike Elif Teker aimed to present coronary artery bypass grafting surgery in a 68-year-old male patient with previous ve Damar Cerrahisi Hastanesi, Eski Londra Asfaltı liver transplantation 12 years ago. Coronary artery bypass grafting operation was performed using left internal mammarian artery and autogenous vein graft for three vessels. There was no complication in the pre- and post-operative periods. Coronary artery bypass grafting operation can be performed safely for patients with previous liver transplantaion in experienced centers.
___
- 1. Faruk C, İsmail H Ö, Mehmet A.Ş, et al. Karaciğer nakli yapılmış hastada açık kalp cerrahisi. Gülhane Tıp Dergisi 2012; 54: 165-7.
- 2. Harrington PB, McAlexander WW, Bryant AS, et al. Outcomes of Patients Who Undergo Cardiac Surgical Procedures After Liver Transplantation. Ann Thorac Surg. 2017; 103:541-5.
- 3. Vogt DP, Henderson JM, Carey WD, Barnes D. The long term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002;132:775-80.
- 4. Canzanello VJ, Schwartz L, Taler SJ. et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997; 3: 1-9.
- 5. Ota T, Rocha R, Wei LM, Toyoda Y, Gleason TG, Bermudez C. Surgical outcomes after cardiac surgery in liver transplant recipients. Thorac Cardiovasc Surg. 2013; 145:1072-6.
- 6. Clarke AT, Mills PR. Atorvastatin associated liver disease. Dig Liver Dis 2006; 38:772-7.
- 7. Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol 2006;97:52-60.
- 8. Onofrei MD, Butler KL, Fuke DC, Miller HB. Safety of statin therapy in patients with preexisting liver disease. Pharmacotherapy 2008;28:522-9.